tamsulosin has been researched along with Cardiovascular Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, K; Jong, JJ; Kakizaki, H; Katoh, T; Katou, D; Lee, KS; Sumarsono, B; Uno, S; Yamaguchi, O; Yamamoto, O | 1 |
| Choo, SH; Han, DH; Kim, JJ; Lee, SW; Sung, HH | 1 |
| Schulman, CC | 1 |
| O'Leary, MP | 1 |
| De la Rosette, JJ; Farmer, RD; Herings, RM; Leufkens, HG; Man in 't Veld, AJ; Souverein, PC | 1 |
2 review(s) available for tamsulosin and Cardiovascular Diseases
| Article | Year |
|---|---|
Tamsulosin modified release and oral controlled absorption system in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Animals; Cardiovascular Diseases; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug and Narcotic Control; Humans; Intestinal Absorption; Male; Prostatic Hyperplasia; Risk Assessment; Sulfonamides; Tamsulosin; Treatment Outcome | 2008 |
Treatment and pharmacologic management of BPH in the context of common comorbidities.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome | 2006 |
2 trial(s) available for tamsulosin and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular safety of mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from the MATCH study.
Topics: Acetanilides; Age Factors; Aged; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Tamsulosin; Thiazoles; Urinary Bladder, Overactive | 2021 |
Efficacy and tolerability of tamsulosin 0.4 mg in Asian patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia refractory to tamsulosin 0.2 mg: a randomized placebo controlled trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Asian People; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Placebos; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urination | 2014 |
1 other study(ies) available for tamsulosin and Cardiovascular Diseases
| Article | Year |
|---|---|
Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Adult; Aged; Bias; Cardiovascular Diseases; Case-Control Studies; Finasteride; Humans; Male; Middle Aged; Morbidity; Netherlands; Prazosin; Prognosis; Prostatic Hyperplasia; Quinazolines; Research Design; Risk Factors; Sulfonamides; Tamsulosin | 2001 |